Vertex Pharmaceutic (VRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 433,551 | 227,301 | 91,635 | -10,550 | 280,717 |
| Depreciation Amortization | 34,402 | 16,343 | 61,397 | 44,965 | 29,740 |
| Income taxes - deferred | 3,516 | 3,587 | -120,513 | -113,969 | 4,626 |
| Accounts receivable | -88,166 | -13,473 | -71,759 | -60,165 | -49,767 |
| Accounts payable and accrued liabilities | 12,229 | 2,154 | 8,753 | 6,925 | 14,047 |
| Other Working Capital | 74,753 | 13,302 | 12,764 | -20,286 | -16,863 |
| Other Operating Activity | 104,075 | 3,443 | 862,665 | 770,511 | 184,845 |
| Operating Cash Flow | $574,360 | $252,657 | $844,942 | $617,431 | $447,345 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -58,891 | -29,279 | -99,421 | -56,437 | -28,477 |
| Purchase Of Investment | -223,502 | -60,153 | -532,581 | -431,653 | -377,667 |
| Sale Of Investment | 171,028 | 94,365 | 369,214 | 247,149 | 168,882 |
| Other Investing Activity | 0 | 0 | -220,541 | -221,602 | 0 |
| Investing Cash Flow | $-111,365 | $4,933 | $-483,329 | $-462,543 | $-237,262 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 9,566 | 9,566 | 34,666 | 4,700 | 0 |
| Debt Repayment | -14,061 | -10,513 | -23,602 | -17,320 | -10,637 |
| Common Stock Issued | 144,837 | 88,403 | 344,840 | 298,205 | 147,887 |
| Common Stock Repurchased | -115,033 | -10,000 | N/A | N/A | 0 |
| Other Financing Activity | 2,439 | 1,500 | -287,500 | -290,412 | -294,782 |
| Financing Cash Flow | $27,748 | $78,956 | $68,404 | $-4,827 | $-157,532 |
| Exchange Rate Effect | -4,201 | 1,656 | 5,802 | 5,001 | 3,500 |
| Beginning Cash Position | 1,667,526 | 1,667,526 | 1,231,707 | 1,231,707 | 1,231,707 |
| End Cash Position | 2,154,068 | 2,005,728 | 1,667,526 | 1,386,769 | 1,287,758 |
| Net Cash Flow | $486,542 | $338,202 | $435,819 | $155,062 | $56,051 |
| Free Cash Flow | |||||
| Operating Cash Flow | 574,360 | 252,657 | 844,942 | 617,431 | 447,345 |
| Capital Expenditure | -58,891 | -29,279 | -99,421 | -56,437 | -28,477 |
| Free Cash Flow | 515,469 | 223,378 | 745,521 | 560,994 | 418,868 |